Cargando…
Risk-benefit assessment of ivabradine in the treatment of chronic heart failure
Heart rate is not only a major risk marker in heart failure but also a general risk marker. Within the last few years, it has been demonstrated that reduction of resting heart rate to <70 bpm is of significant benefit for patients with heart failure, especially those with impaired left ventricula...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010635/ https://www.ncbi.nlm.nih.gov/pubmed/24855390 http://dx.doi.org/10.2147/DHPS.S43275 |